Order Article Reprints

D’Angelo A, Giudici F, Chapman R, Darlow J, Kilili H, Sobhani N, Cinelli M, Cappelletti MR, Strina C, Milani M, et al. Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2− Breast Cancer Based on a Window of Opportunity Study. Current Issues in Molecular Biology. 2022; 44(9):4255-4267. https://doi.org/10.3390/cimb44090292

D’Angelo, Alberto, Fabiola Giudici, Robert Chapman, Jacob Darlow, Huseyin Kilili, Navid Sobhani, Mattia Cinelli, Maria Rosa Cappelletti, Carla Strina, Manuela Milani, and et al. 2022. "Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2− Breast Cancer Based on a Window of Opportunity Study" Current Issues in Molecular Biology 44, no. 9: 4255-4267. https://doi.org/10.3390/cimb44090292

D’Angelo, A., Giudici, F., Chapman, R., Darlow, J., Kilili, H., Sobhani, N., Cinelli, M., Cappelletti, M. R., Strina, C., Milani, M., & Generali, D. (2022). Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2− Breast Cancer Based on a Window of Opportunity Study. Current Issues in Molecular Biology, 44(9), 4255-4267. https://doi.org/10.3390/cimb44090292